Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery

被引:42
作者
Boon, H. [1 ]
Blaak, E. E.
Saris, W. H. M.
Keizer, H. A.
Wagenmakers, A. J. M.
van Loon, L. J. C.
机构
[1] Maastricht Univ, Dept Human BiolNutr & Toxicol, Res Inst Maastricht, NUTRIM, Maastricht, Netherlands
[2] Maastricht Univ, Dept Movement Sci, NUTRIM, Maastricht, Netherlands
[3] Free Univ Brussels, Dept Human Physiol & Sportsmed, Brussels, Belgium
[4] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham, W Midlands, England
关键词
exercise; IMTG; stable isotopes; substrate source metabolism; type; 2; diabetes;
D O I
10.1007/s00125-006-0482-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disturbances in substrate source metabolism and, more particularly, in fatty acid metabolism, play an important role in the aetiology and progression of type 2 diabetes. However, data on substrate source utilisation in type 2 diabetes are inconclusive. [U-C-13]palmitate and [6,6-H-2(2)]glucose tracers were used to assess plasma NEFA and glucose oxidation rates and to estimate the use of muscle- and/or lipoprotein-derived triacylglycerol and muscle glycogen. Subjects were ten male patients who had a long-term (7 +/- 1 years) diagnosis of type 2 diabetes and were overweight, and ten matched healthy, male control subjects. Muscle biopsy samples were collected before and after exercise to assess muscle fibre type-specific intramyocellular lipid and glycogen content. At rest and during exercise, the diabetes patients had greater values than the controls for palmitate rate of appearance (Ra) (rest, 2.46 +/- 0.18 and 1.85 +/- 0.20 respectively; exercise, 3.71 +/- 0.36 and 2.84 +/- 0.20 mu mol kg(-1) min(-1)) and rate of disappearance (Rd) (rest, 2.45 +/- 0.18 and 1.83 +/- 0.20; exercise, 3.64 +/- 0.35 and 2.80 +/- 0.20 mu mol kg(-1) min(-1) respectively). This was accompanied by significantly higher fat oxidation rates at rest and during recovery in the diabetes patients (rest, 0.11 +/- 0.01 in diabetes patients and 0.09 +/- 0.01 in controls; recovery, 0.13 +/- 0.01 and 0.11 +/- 0.01 g/min respectively), despite significantly greater plasma glucose Ra, Rd and circulating plasma glucose concentrations. Furthermore, exercise significantly lowered plasma glucose concentrations in the diabetes patients, as a result of increased blood glucose disposal. This study demonstrates that substrate source utilisation in long-term-diagnosed type 2 diabetes patients, in whom compensatory hyperinsulinaemia is no longer present, shifts towards an increase in whole-body fat oxidation rate and is accompanied by disturbances in fat and carbohydrate handling.
引用
收藏
页码:103 / 112
页数:10
相关论文
共 46 条
[1]   Ceramide content is increased in skeletal muscle from obese insulin-resistant humans [J].
Adams, JM ;
Pratipanawatr, T ;
Berria, R ;
Wang, E ;
DeFronzo, RA ;
Sullards, MC ;
Mandarino, LJ .
DIABETES, 2004, 53 (01) :25-31
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]  
BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787
[5]   Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle [J].
Blaak, EE ;
Wagenmakers, AJM ;
Glatz, JFC ;
Wolffenbuttel, BHR ;
Kemerink, GJ ;
Langenberg, CJM ;
Heidendal, GAK ;
Saris, WHM .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (01) :E146-E154
[6]   Fatty acid metabolism in obesity and type 2 diabetes mellitus [J].
Blaak, EE .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2003, 62 (03) :753-760
[7]   The fate of [U-13C] palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects [J].
Blaak, EE ;
Wagenmakers, AJM .
DIABETES, 2002, 51 (03) :784-789
[8]   Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise [J].
Blaak, EE ;
van Aggel-Leijssen, DPC ;
Wagenmakers, AJM ;
Saris, WHM ;
van Baak, MA .
DIABETES, 2000, 49 (12) :2102-2107
[9]   Substrate utilization in non-obese Type II diabetic patients at rest and during exercise [J].
Borghouts, LB ;
Wagenmakers, AJM ;
Goyens, PLL ;
Keizer, HA .
CLINICAL SCIENCE, 2002, 103 (06) :559-566
[10]   FAT-METABOLISM IN HUMAN OBESITY [J].
CAMPBELL, PJ ;
CARLSON, MG ;
NURJHAN, N .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :E600-E605